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The aim of the current study is to investigate how to improve predictions from Gaussian Process models by optimising the model hyperparameters. 

Methods
Optimisation methods, including Grid Search, Conjugate Gradient, Random Search, Evolutionary Algorithm and Hyper-prior, were evaluated and applied to previously published data. Data sets were also altered in a structured manner to reduce their size, which retained the range, or ‘chemical space’ of the key descriptors in order to assess the effect of the data range on model quality. 

Key findings
The Smoothbox Hyper-prior kernel results in the best models for the majority of data sets and they exhibited significantly better performance than benchmark QSPR models. When the data sets were systematically reduced in size the different optimisation methods generally retained their statistical quality whereas benchmark QSPR models performed poorly. 

Conclusions
















Measurement of the percutaneous absorption of exogenous chemicals has become increasingly important over the last 25 years for a variety of reasons, including pharmaceutical efficacy and, in a number of fields, toxicity. The current ‘gold standard’ for initial assessment of in vitro percutaneous absorption is an experiment using excised human or porcine skin and which follows the protocol presented in OECD 428 [1]. 

Since the publication of the Flynn data set [2] there has been considerable interest in the development of mathematical models that relate the percutaneous absorption of exogenous chemicals to the physicochemical properties of permeants. This began with the work of El Tayer [3] and has grown into a distinct area of research, mostly based on the use of a range of methods to interrogate the Flynn data set, or variations thereon. The early work in this field was predominately based on quantitative structure-permeability relationships (QSPRs) and has been comprehensively reviewed previously [4]. 

However, in the context of percutaneous absorption many QSPR models have been shown to be significantly limited in their predictive ability, for example where some of the most commonly used QSPR models were shown to poorly correlate with experimental data which covered the stated range of applicability of these models [5, 6]. Despite their advantages QSPRs have therefore gained little widespread use or credibility in the broader field of percutaneous absorption. 

More recently, a range of novel methods has been applied to this problem domain. Such methods, including the use of non-linear models [55, 56], parallel artificial membrane permeability assay (PAMPA) methods [56] and Machine Learning methods such as Gaussian Process Regression [7], offer significant improvements in predictive ability over QSPR models. However, they are often criticised as non-linear methods are perceived to over-fit in many situations and Machine Learning methods are limited by their lack of transparency as they are predominately based on ‘black-box’ methods, which mean that they are seldom represented by a discrete algorithm. Despite studies which in different ways address this issue [8, 9] the uptake of such methods in the field of percutaneous absorption has been limited and is due mostly to the lack of ease of use of what can often be quite advanced computation techniques by non-specialists. Nevertheless, despite their more rudimentary nature when compared to Machine Learning methods, and previous studies highlighting comparatively poor performance for QSPR methods compare to Machine Learning methods [8, 20, 24], QSPRs are still considered by many researchers in this field to be the benchmark predictive method and are used in this study in that regard.

Another significant limitation in using computational methods in estimating percutaneous absorption is the construction of the model and, implicitly, the need for a high-quality and consistent data set to underpin this development. The necessary amounts of reliable and consistent data have been discussed previously [10]. From the Machine Learning point of view, there is considerable difficulty in using Flynn’s original dataset and other datasets derived from it in that the reported value of skin permeability for the same chemical varies considerably. This may be due to experimental artefacts, such as the anatomical location from which skin was excised for each experiment, or experimental temperature, which may affect the accuracy of resultant models [11]. This presents a significant challenge in the production of a new data set from a single source, which may be expected to yield more accurate models with reduced variance. 

Nevertheless, one of the key issues in the development of improved models is the difficulty of developing new data sets. For example, a contract research organisation will commonly charge a significant sum to produce absorption data for one chemical (i.e. one data point) and the production of approximately 100 data points using the same method to construct a viable model is therefore, in purely financial terms, very costly and in all probability unrealistic. Thus, generation of new datasets may not reflect the needs of model development which sits apart from a specific study. In particular, industrially-focused studies may be targeted to a specific group of chemicals and this may not fit the needs of a model. In addition, data quality may be affected by variable methodological approaches or by the collation of data from a range of studies.









Nine human and animal skin datasets collated from various sources have been used in this study. All data has been taken from previously published literature studies and does not require ethical approval for its subsequent use. The sizes of the datasets vary from 14 to 85 after refining the data by, for example, removing ambiguous data or values which are listed as ‘greater than’ or ‘less than’ a fixed value, rather than a discrete number. Other refinement processes include removing all the repetitions and obtaining the mean value of the targets for the same chemicals with the same molecular features and different target values [9, 12]. The number of data records in each dataset after refinement is shown in Table 1. The small size is due to the fact that gathering consistent pharmaceutical data which is generated from the same or similar protocols is difficult, time consuming, and expensive. This is usually because of the inherent biological variation of such data, and that the data is generated for other purposes and not primarily for its inclusion in predictive models. Table 2 shows the whole data set, originally obtained from Magnusson’s Set A (see Table 1), which is used for analysis of subsets.

[INSERT TABLE 1 HERE]

[INSERT TABLE 2 HERE]


2 Gaussian Process Regression (GPR)

Gaussian Process Regression (GPR) is a technique of increasing importance in the Machine Learning field, and which is finding greater utility in the physical and biological sciences [8, 13 – 16, 22]. This technique has been reported on and reviewed extensively elsewhere and the reader is directed to those sources for further information [9, 15 – 24].






A range of methods were used for analysis of the data. Gaussian Process methods with a range of kernels, and a range of methods to vary the model hyperparameters (the Conjugate Gradient, Grid Search, Random Search, Hyper-Prior methods and Evolutionary Algorithms) were employed. The Gaussian Process modelling methods for non-linear regression used previously were again adopted for this study [7, 8, 19, 22]. The latest version of the Hyper Prior optimisation Toolbox was also used [21]. The MatLab Genetic Algorithm (GA) optimisation toolbox was used to carry out the Evolutionary Algorithm hyperparameter optimisation. Quantitative structure-permeability relationships (QSPRs) were used as benchmarks [25, 26].

3.2 Cross-validation
The importance of model validation in constructing computational models has been discussed previously [27]. In this study, we have validated models using the cross-validation technique [28]. 5-fold cross-validation was performed. The datasets were shuffled and divided into 5 ‘folds’. Each time one of the folds was considered as the test set and the remaining four were considered as the training set. At this point, a validation set was removed from the training set. The hyperparameter optimisation methods were then applied to the training set and the prediction performances were gained for the validation set. This was then repeated for the other 3 possible validation sets. The best hyperparameters were chosen as those performed best over the four validation sets (the minimum average MSLL values, which are defined in Section 4). They were used to predict the permeability values of the test set. 

3.3 Initialisation of experiments
The experiments were initialised as follows:
	Grid search: The hyperparameters were considered as a range [10-3, 103] with 20 equidistant steps. Using a 5-fold cross validation the model was trained with all the 8,000 (20 x 20 x 20) different sets of the hyperparameters and the predictions obtained for the test sets. On inspecting the prediction performances on the validation sets a finer search for better values of the hyperparameters was then performed with the search range limited to [0.01, 10] with 20 steps as no better results were obtained using the hyperparameters outside this range. The model was then trained with the new hyperparameters and tested on the test sets. The average values and their standard deviation among 5-folds were then reported.
	Random search: 20 values for each hyperparameter were obtained randomly within the same range [0.01, 10] considered in the grid search. Using 5-fold cross validation the model was then trained and the predictions obtained. Since, in each run of this experiment, the hyperparameters were selected randomly the experiment was repeated 5 times and the results were obtained by calculation of the mean and standard deviation of the experiment’s results. 
	Conjugate gradient: The hyperparameters were initialised to log (0.5) with the number of function evaluations set to 100.
	Hyper Prior methods: The mean and variance parameters of the Gaussian and Laplacian priors were set to constant values of 0.1 and 0.01, respectively and were obtained as the best prediction performances using cross-validation in each of the data sets. For the Smooth Box Prior method, a, b and  values were set to 10-3, 10 and 2, respectively. Various values of  were evaluated and the value 2 was found to be the best value for the data sets used in this study.
	Evolutionary algorithm: Following an evaluation of ratios ranging from 0.1 to 1.2, the heuristic crossover function with a ratio of 0.7 was used to accelerate convergence as it was found to have the optimum performance for the data sets used. Each of the 50 generations has a population of 50 and the optimised hyperparameters were obtained from the last generation. The ‘Elite’ Children value was set to 4 and the mutation function was kept uniform, meaning that the children were randomly selected from a uniform distribution within the range of hyperparameters. The crossover fraction was set to 0.8 (0.8 * 50 = 40), meaning that the rest of the children in a population are 4 Elite children and 6 children were obtained from mutation. The population of the first generation was initialised randomly and was therefore similar to the Random Search. This experiment was repeated five times using the Genetic Algorithm Toolbox in MatLab.

3.4 Data set analysis
The different data sets used in this study were characterised in terms of their membership (data set size) and range (the range of physicochemical descriptors used). Data used are those published previously [29, 30] and are shown in Tables 1 and 2. 

3.5 The effect of the size of the data set and the range of the physicochemical descriptor values on prediction performance

Due to their ubiquitous use in this field, and their relevance as benchmarks in this study, the effects of molecular weight and lipophilicity (as log P or log Ko/w) were considered [4]. The first experiment considered how changes to the size (membership) of the data set affected the statistical quality of the resultant models whilst maintaining the range, or ‘chemical space’, of each model. The data set reported previously by Magnusson [29] was used for this experiment. In separate experiments this data set was used to construct four smaller subsets that maintained the range of descriptors of the original data set (Table 2). To construct these data sets four subsets (of size 44, 33, 17 and 9) were chosen from the Magnusson data set. Chemicals were selected only to ensure that the maximum and minimum MW ranges were maintained across all the data sets. The GPR model was then trained with each data set, with the hyper-prior Smoothbox and conjugate gradient optimisation methods employed to set the best hyperparameters for the models. As a benchmark the QSPR reported previously [26] was used, with a concentration correction to adjust between kp and Jmax, as the Potts and Guy QSPR model [25] did not perform well in the initial analysis. This experiment was repeated with subsets of the Magnusson data set which maintained the range of log P values across all data sets whilst reducing the data set membership. Subsets in both experiments were of the same size. 






The correlation coefficient (r), Mean Standard Log Loss (MSLL) [22] and improvement over the naïve model (ION, where the naïve model always predicts the mean of the target value in the training set independently of the input), were used, as in previous studies, to determine the model performance [8, 20, 24]. The correlation coefficient is a widely used performance measure in this problem domain. Our experiences from our previous work tell us that ION is a good indicator and measures how much better a predictor is than the naïve predictor. In addition, since Gaussian Process Regression (GPR) can produce a predictive distribution at each test input, it is common to evaluate a GPR model using the negative log probability (NLL) of the target under the model in the applied Machine Learning field. Furthermore, MSLL measures how much better a predictor is than a trivial model, which predicts using a Gaussian with the mean and variance of the training set [22].







Selection of optimum hyperparameter method

The statistical measures (MSLL, ION and r) used to assess the quality of the different hyperparameter methods are shown in Table 3. The data sets in Table 3 are listed based on size, from the largest to the smallest, taken from the dataset published previously [29]. The best results for each data set are shown in bold text, and the worst result shown in underlined text.

[INSERT TABLE 3 HERE]

The MSLL results indicate that the smooth box hyper-prior kernel works better than the other methods for the majority of the datasets. It generally shows a good performance for all datasets irrespective of size. The ION and correlation coefficient results also show that this method results in better prediction performances for four of the datasets. A benchmark analysis using the Potts and Guy QSPR model [25], and comparing the correlation coefficients only, performs significantly worse than all the other methods in all the datasets. The results in Table 3 indicate that the hyper-prior Smoothbox method produces, independently of the performance measures used, the best overall performance for the majority of data sets. The inconsistency between ION and MSLL results may be a result of small data sets as the predictive variance, which is part of MSLL but not ION, is generally so much more variable in smaller data sets.  Using the Evolutionary Algorithm (EA) to optimise the hyperparameters generally works better, in terms of performance measures, for larger data sets than for smaller data sets. In this study, the worst performances from application of the EA method are found with the smallest data sets. 

Table 3 also shows that the outcomes from the grid search and random search hyperparameter optimisation methods were broadly similar in their performance measures. This partially mirrors previously reported findings [31]. Interestingly, in this study whilst both methods were generally positive they were not the best methods tested to optimise the hyperparameters. This may be due to the limitations of these methods in searching a space of three hyperparameters which are limited to a number of points in that space – in this case this is 20 x 20 x 20 = 8000 – and that a manual manipulation of these spaces may optimise model performance. It also appears that small changes in certain hyperparameter values exerts a significant impact on the results generated by these techniques. The implication for this is that, for either small data sets or sources of variable data, small differences in the analytical techniques used to generate outputs may have significant implications for the accuracy of the resultant predictions. 

It is also important to note that the hyper-prior optimisation method outperforms the conjugate gradient method, even though the latter is the method most commonly used to optimise hyperparameters in GPR [17]. This is shown in Figure 1, where the comparison of MSLL values is shown for a range of optimisation methods, and the Smoothbox hyper-prior method clearly outperforms the conjugate gradient method for the majority of data sets. A smaller standard deviation of MSLL is obtained when the hyper-prior method was used compared to the conjugate gradient method. 

[INSERT FIGURE 1 HERE]

[INSERT FIGURE 2 HERE]

The effect of the size of the data set and the range of the physicochemical descriptor values on prediction performance 

The results from altering the data set memberships are shown in Table 4. The most significant finding is that decreasing the size of the data set (from 85 to 9 members) but maintaining the maximum range of molecular weight does not significantly affect the good performance of the model. In all cases where the statistical measure does fall – for example, with the smallest data sets, the drop in the correlation coefficient, for example, is to 0.88 or 0.83, depending on the hyperparameter optimisation method used (Table 4).  Overall, similar results are obtained for the different GPR hyperparameter optimisation methods. 

[INSERT TABLE 4 HERE]

When the data set membership is decreased and the range of log P values kept constant the statistical quality of the models is not substantially affected. However, the outcomes of this study are not as clear-cut as the previous experiment. While model performance increases in some cases with decreasing data sets – for example, increases in ION from 0.93 to 0.94 are observed, model performance declines in other cases. Such decreases are shown in Table 4 and include reduction in ION of 0.93 to 0.72, and from 0.93 to 0.80, for the Smoothbox and conjugate gradient methods, respectively. This illustrates not only the importance of a correct data set design when conducting modelling experiments [11] but also the importance of transparency in model construction and use [33]. This again highlights the importance of the range of significant physicochemical descriptors and how they may affect the resultant model and its predictions of skin permeability. 

That the data range should be as wide as possible also has an implication on the descriptor choice, despite previous GPR studies [8, 24] indicating that a certain degree of interchangeability between parameters due to covariance might be significant in flexibly generating models of the same statistical quality. For example, an examination of previously published data sets [26, 29, 33] indicates that the majority of chemicals present in those data sets have a small number of hydrogen bonding groups – usually from zero to three. If the implications of these studies are valid, it may be hypothesised that little improvement in GPR models would be seen even if hyperparameter optimisation is conducted. 





Using the hyper-prior Smoothbox method to optimise the GPR hyperparameters works better than other hyperparameter optimisation methods and does so independently of the data and the performance measure methods used to characterise model quality. This method optimised GPR results in models with a better statistical performance than previous GPR models where hyperparameters are not optimised [8, 24]. Both of these approaches are significantly better than established QSPR models [25, 26]. 

Whilst hyperparameter optimisation improved model quality and maintained the performance measures it should not be used in isolation; even in small data sets there was variation within the chosen method of hyperparameter optimisation, with the Smoothbox method producing the best outcomes in the majority of situations. Investigation of the physicochemical descriptors used in this data set suggests that the data set range and not necessarily the population should be as wide as possible.

The nature of the analysis is also examined in this study. Comparison of data sets where the membership is kept constant whilst the range of significant chemical features is altered generally indicated that the range of test and training sets needs to be maintained, as it may be inferred that not doing so may lead to issues of variability in performance due to how the model is trained, and with which data the model is tested with. The methods used in this study were based on well-established methods of random data selection for training and test sets (Section 3.5), such as cross-validation and “leave n-out” approaches. This includes the generation of multiple random sets of training and test data, and the average value of these data sets is generally reported. However, in considering the applicability domain of training and test sets this might impact on the quality of predictions obtained. In some cases (e.g. Magnusson dataset A) this may to some degree influence the results obtained. In some cases chemicals with the worst predictions have at least one physicochemical feature that is ‘abnormal’ (too large or too small) when compared to the rest of the datasets. This is by no means a common feature across all datasets but it does offer a reasonable explanation for poor predictive ability in these specific cases. This may potentially be an artefact associated with the random setup of training and test sets. 
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Comparison of MSLL performances for the Conjugate Gradient and Hyper-prior Smoothbox methods for each dataset.

Figure 2. Range of physicochemical descriptors in the datasets used in this study.

Table 1.
Summary of the data sets used in this study.

Table 2.
Dataset used for analysis of subsets. Data is taken from Magnusson’s study [29, 35 – 54] and subdivisions of this data are shown for studies where the systematic reduction of dataset size was undertaken whilst retaining the range of key parameters (log Kow, MW).
Note: 	Where the log Kow (log P) range is maximised, the range is from -4.67 to 4.52 for datasets of all sizes and MW ranges are: dataset (n = 9), 46 to 316.5; dataset (n = 17), 18 to 434.5; dataset (n = 33), 32 to 434.5; dataset (n = 44), 32 to 476.6.




Statistical performance measures (MSLL, correlation coefficient and ION) used to determine the performance of each method for the range of tests evaluated in this study. Note: for each optimization method or test the best performing models are shown in bold text, and those with the worst performance are shown in underline. Note: 1Taken from [29]; 2Taken from [30].

Table 4.









Dataset	Number of data points	Number of descriptors used	Descriptors used	Target	Reference
Human A	21	5	log P, MW, HA, HD, SP	log kp	[7, 30]
Human B	84	5	log P, MW, HA, HD, SP	log kp	[7, 30]
Rat	26	5	log P, MW, HA, HD, SP	log kp	[7, 30]
Mouse	46	5	log P, MW, HA, HD, SP	log kp	[7, 30]
Pig	14	5	log P, MW, HA, HD, SP	log kp	[7, 30]
Magnusson Set A (t)	85	6	log P, MPt, MW, HA, HD, Texp	Jmax	[29]
Magnusson Set B (Vs)	50	6	log P, MPt, MW, HA, HD, Texp	Jmax	[29]
Magnusson Set C (Vp)	27	6	log P, MPt, MW, HA, HD, Texp	Jmax	[29]
Magnusson Set D (Vf)	45	6	log P, MPt, MW, HA, HD, Texp	Jmax	[29]




Table 2.  

Chemical Number (from [29])	Chemical name	Experimental temperature  (K)	MW	 log Kow  (log P)	MPt (K)	 HD 	HA	log Jmax	Dataset maintaining the range of MW values but reducing, from subset 1 to subset 4, the size of the dataset.	Dataset maintaining the range of logP values but reducing, from subset 1 to subset 4, the size of the dataset.	References (source of data)























































































Note: 	Where log P is the octanol-water partition coefficient, represented by log Kow in the original paper [29]; HA and HD represent the number of hydrogen bond acceptor and donor groups on a molecule, respectively; MW is the molecular weight; MPt is the melting point; Texp is the experimental temperature. 







Dataset	Grid search	Random search	Conjugate Gradient 	Hyper-prior (Gaussian)	Hyper-prior (Laplace)	Hyper-prior (Smoothbox)	Evolutionary algorithm	QSPR (correlation (r) only)
Correlation coefficient, r
Magnusson Set A1	0.96 ± 0.01	0.96 ± 0.01	0.97 ± 0.01	0.96 ± 0.02	0.96 ± 0.02	0.97 ± 0.02	0.97 ± 0.02	0.10±0.14
Human B2	0.59 ± 0.15	0.60 ± 0.15	0.60 ± 0.14	0.64 ± 0.11	0.64 ± 0.11	0.63 ± 0.11	0.64 ± 0.11	0.08±0.20
Magnusson Set B1	0.93 ± 0.05	0.90 ± 0.05	0.94 ± 0.05	0.85 ± 0.11	0.83 ± 0.12	0.96 ± 0.03	0.95 ± 0.03	0.38±0.16
Mouse2	0.52 ± 0.40	0.52 ± 0.40	0.50 ± 0.44	0.51 ± 0.39	0.53 ± 0.37	0.51 ± 0.35	0.50 ± 0.39	-0.38±0.37
Magnusson Set D1	0.59 ± 0.31	0.56 ± 0.31	0.59 ± 0.31	0.60 ± 0.25	0.62 ± 0.28	0.55 ± 0.27	0.54 ± 0.25	-0.18±0.48
Magnusson Set C1	0.83 ± 0.13	0.83 ± 0.13	0.81 ± 0.11	0.63 ± 0.24	0.65 ± 0.23	0.80 ± 0.15	0.75 ± 0.03	-0.77±0.23
Rat2	0.15 ± 0.72	0.18 ± 0.71	0.19 ± 0.68	0.53 ± 0.56	0.56 ± 0.49	0.56 ± 0.49	0.08 ± 0.81	0.30±0.64
Human A2	0.74 ± 0.17	0.74 ± 0.17	0.73 ± 0.19	0.77 ± 0.15	0.77 ± 0.17	0.77 ± 0.16	0.70 ± 0.16	0.37±0.45
Pig2	0.84 ± 0.01	0.92 ± 0.18	0.87 ± 0.01	0.85 ± 0.01	0.85 ± 0.01	0.87 ± 0.01	0.65 ± 0.36	0.29±0.31
MSLL
Magnusson Set A1	-1.33 ± 0.21	-1.32 ± 0.02	-1.35 ± 0.14	-0.97 ± 0.06	-0.99 ± 0.04	-1.35 ± 0.10	-1.10 ± 0.02	-
Human B2	-0.22 ± 0.35	-0.15 ± 0.07	1.17 ± 2.90	-0.16 ± 0.07	-0.15 ± 0.07	-0.27 ± 0.10	-0.20 ± 0.01	-
Magnusson Set B1	-0.95 ± 0.28	-0.98 ± 0.02	-0.98 ± 0.21	-0.56 ± 0.14	-0.62 ± 0.11	-0.99 ± 0.18	-0.80 ± 0.06	-
Mouse2	0.07 ± 0.56	0.74 ± 0.48	0.72 ± 0.86	-0.02 ± 0.07	-0.06 ± 0.11	-0.13 ± 0.28	-0.10 ± 0.01	-
Magnusson Set D1	-0.22 ± 0.22	-0.18 ± 0.02	-0.18 ± 0.19	-0.12 ± 0.12	-0.23 ± 0.21	-0.15 ± 0.15	-0.10 ± 0.01	-
Magnusson Set C1	-0.20 ± 0.80	-0.17 ± 0.17	-0.20 ± 0.82	-0.15 ± 0.06	-0.12 ± 0.43	-0.40 ± 0.32	-0.30 ± 0.04	-
Rat2	-0.04 ± 0.76	-0.10 ± 0.14	-0.31 ± 0.30	-0.11 ± 0.07	-0.37 ± 0.29	-0.43 ± 0.29	0.16 ± 0.15	-
Human A2	-0.22 ± 0.27	-0.14 ± 0.10	-0.23 ± 0.26	-0.13 ± 0.15	-0.32 ± 0.27	-0.16 ± 0.14	-0.10 ± 0.06	-
Pig2	-0.98 ± 0.37	-1.01 ± 0.09	-0.90 ± 0.36	-0.50 ± 0.15	-0.93 ± 0.43	-0.72 ± 0.31	-0.00 ± 0.42	-
ION
Magnusson Set A1	0.91 ± 0.02	0.91 ± 0.00	0.93 ± 0.02	0.89 ± 0.03	0.91 ± 0.02	0.93 ± 0.02	0.93 ± 0.00	-
Human B2	0.34 ± 0.21	0.32 ± 0.01	0.36 ± 0.17	0.41 ± 0.13	0.41 ± 0.14	0.41 ± 0.16	0.41 ± 0.01	-
Magnusson Set B1	0.82 ± 0.08	0.77 ± 0.02	0.84 ± 0.08	0.67 ± 0.17	0.69 ± 0.18	0.85 ± 0.07	0.82 ± 0.02	-
Mouse2	0.28 ± 0.31	0.27 ± 0.06	0.24 ± 0.38	0.29 ± 0.29	0.32 ± 0.27	0.28 ± 0.32	0.23 ± 0.01	-
Magnusson Set D1	0.24 ± 0.27	0.20 ± 0.03	0.24 ± 0.28	0.21 ± 0.14	0.30 ± 0.22	0.22 ± 0.18	0.23 ± 0.02	-
Magnusson Set C1	0.55 ± 0.23	0.55 ± 0.01	0.47 ± 0.22	0.30 ± 0.17	0.42 ± 0.20	0.47 ± 0.21	0.39 ± 0.02	-
Rat2	0.10 ± 0.58	0.08 ± 0.04	0.24 ± 0.25	0.31 ± 0.21	0.29 ± 0.34	0.40 ± 0.20	0.00 ± 0.22	-
Human A2	0.27 ± 0.30	0.24 ± 0.09	0.27 ± 0.27	0.30 ± 0.14	0.38 ± 0.24	0.29 ± 0.13	0.14 ± 0.05	-
Pig2	0.77 ± 0.18	0.81 ± 0.06	0.82 ± 0.13	0.65 ± 0.16	0.82 ± 0.14	0.80 ± 0.13	0.45 ± 0.11	-
1.	Magnusson et al., 2004







Performance / subsets	Original dataset and subsets which maintain a full range of molecular weight, based on the original dataset1	Original dataset and subsets which maintain a full range of log P, based on the original dataset1	Original dataset and subsets2 in which the range of molecular weight is systematically reduced, based on the original dataset1	Original dataset and subsets2 in which the range of log P is systematically reduced, based on the original dataset1
	Magnusson	Subset 1	Subset 2	Subset 3	Subset 4	Magnusson	Subset 1	Subset 2	Subset 3	Subset 4	Magnusson	Subset 1	Subset 2	Subset 3	Subset 4	Magnusson	Subset 1	Subset 2	Subset 3	Subset 4
Size of dataset	85	44	33	17	9	85	44	33	17	9	85	40	40	40	40	85	40	40	40	40
ION (Smoothbox hyper-prior)	0.93	0.92	0.91	0.88	0.90	0.93	0.90	0.93	0.94	0.72	0.93	0.11 ± 0.05	0.68 ± 0.29	0.81 ± 0.10	0.91 ± 0.03	0.93	0.92 ± 0.03	0.90 ± 0.02	0.89 ± 0.07	0.91 ± 0.04
ION (conjugate gradient)	0.93	0.89	0.90	0.87	0.88	0.93	0.89	0.92	0.94	0.80	0.93	0.10 ± 0.05	0.66 ± 0.30	0.80 ± 0.10	0.90 ± 0.03	0.91	0.90 ± 0.03	0.90 ± 0.02	0.88 ± 0.07	0.90 ± 0.04
MSLL (Smoothbox hyper-prior)	-1.35	-1.20	-1.06	-0.88	-0.99	-1.35	-1.04	-1.1	-1.02	-0.98	-1.35	-1.18 ± 0.64	-2.09 ± 0.73	-1.26 ± 0.19	-1.05 ± 0.27	-1.35	-1.10 ± 0.43	-1.07 ± 0.15	-1.02 ± 0.28	-1.15 ± 0.23
MSLL (conjugate gradient)	-1.35	-1.08	-1.06	-0.86	-1.06	-1.35	-1.04	-1.1	-1.02	-1.23	-1.35	-1.76 ± 0.69	-2.10 ± 0.72	-1.22 ± 0.23	-1.00 ± 0.28	-1.35	-0.66 ± 1.76	-0.90 ± 0.62	-0.94 ± 0.47	-1.10 ± 0.24
Correlation coefficient (Smoothbox hyper-prior)	0.97	0.97	0.93	0.83	0.97	0.97	0.96	0.97	0.85	0.88	0.97	0.34 ± 0.22	0.73 ± 0.09	0.89 ± 0.05	0.95 ± 0.01	0.97	0.95 ± 0.02	0.95 ± 0.01	0.94 ± 0.04	0.95 ± 0.03
Correlation coefficient (conjugate gradient)	0.97	0.97	0.93	0.83	0.89	0.97	0.96	0.97	0.85	0.90	0.97	0.32 ± 0.30	0.73 ± 0.11	0.88 ± 0.05	0.94 ± 0.01	0.97	0.95 ± 0.02	0.94 ± 0.01	0.94 ± 0.05	0.95 ± 0.03
Correlation coefficient (aqueous solubility)2	0.56	0.60	0.60	0.49	0.27	0.56	0.50	0.66	0.68	0.41	0.56	0.59 ± 0.16	0.59 ± 0.16	0.59 ± 0.16	0.59 ± 0.16	0.56	0.59 ± 0.16	0.59 ± 0.16	0.59 ± 0.16	0.59 ± 0.16
Correlation coefficient (aqueous solubility, adjusted to temperature)2	0.55	0.59	0.59	0.47	0.24	0.55	0.48	0.64	0.67	0.38	0.55	0.58 ± 016	0.58 ± 0.16	0.58 ± 0.16	0.58 ± 0.16	0.55	0.58 ± 0.16	0.58 ± 0.16	0.58 ± 0.16	0.58 ± 0.16
1.	From [29]
2.	The range of values reduces from Subset 4 to Subset 1 



